Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-09

Clinical Trial Update: Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating topical afimoxifene for breast cancer patients who have undergone radiation therapy on one breast; currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Afimoxifene (topical) (afimoxifene)

Snippet

Sponsor: Northwestern University | Conditions: Cancer Survivor, Ductal Breast Carcinoma In Situ | Phase 2 | Status: ACTIVE_NOT_RECRUITING